Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Until this week, everything was going marvellously. My size 12 jeans were gaping at the waistline, and I could slip into a ...

SURPASS-2 was an open label, 40-week, phase-3 trial which randomized patients to receive once-weekly injections of Mounjaro at a dose of 5 mg, 10 mg, or 15 mg, or Ozempic at a dose of 1 mg.

Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

Read on to learn more about hair loss and GLP-1 agonists as well as more common side effects to expect with Mounjaro. dulaglutide (Trulicity) manage blood sugar levels in people with type 2 ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

From the 17th of February this year, Mounjaro will be licenced for use as a treatment in Ireland for both type 2 diabetes and obesity. Maura Fay spoke to Dr Michael Crotty, clinical lead for ...